Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. (Record no. 30274482)

MARC details
000 -LEADER
fixed length control field 02145 a2200589 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518065813.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202012s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2055-6845
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/ehjcvp/pvz061
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Nicolau, André M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20201201
245 00 - TITLE STATEMENT
Title Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European heart journal. Cardiovascular pharmacotherapy
Date of publication, distribution, etc. 07 2020
300 ## - PHYSICAL DESCRIPTION
Extent 167-175 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anticoagulants
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Atrial Fibrillation
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Comorbidity
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Factor Xa Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Assessment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Stroke
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thiazoles
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thromboembolism
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Warfarin
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Corbalan, Ramon
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nicolau, Jose C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ruff, Christian T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zierhut, Wolfgang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kerschnitzki, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Duris, Tibor
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Juul-Möller, Steen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Voitk, Juri
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Trevisan, Marco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nordio, Francesco
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Antman, Elliott M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Giugliano, Robert P
773 0# - HOST ITEM ENTRY
Title European heart journal. Cardiovascular pharmacotherapy
Related parts vol. 6
-- no. 3
-- p. 167-175
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/ehjcvp/pvz061">https://doi.org/10.1093/ehjcvp/pvz061</a>
Public note Available from publisher's website

No items available.